Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Restrictive Versus Massive Fluid Resuscitation Strategy (REFILL study), influence on blood loss and hemostatic parameters in obstetric hemorrhage: study protocol for a randomized controlled trial.
de Lange N, Schol P, Lancé M, Woiski M, Langenveld J, Rijnders R, Smits L, Wassen M, Henskens Y, Scheepers H. de Lange N, et al. Among authors: rijnders r. Trials. 2018 Mar 6;19(1):166. doi: 10.1186/s13063-018-2512-z. Trials. 2018. PMID: 29510717 Free PMC article.
Well being of obstetric patients on minimal blood transfusions (WOMB trial).
Prick BW, Steegers EA, Jansen AJ, Hop WC, Essink-Bot ML, Peters NC, Uyl-de Groot CA, Papatsonis DN, Akerboom BM, Metz GC, Bremer HA, van Loon AJ, Stigter RH, van der Post JA, van Alphen M, Porath M, Rijnders RJ, Spaanderman ME, Schippers DH, Bloemenkamp KW, Boers KE, Scheepers HC, Roumen FJ, Kwee A, Schuitemaker NW, Mol BW, van Rhenen DJ, Duvekot JJ. Prick BW, et al. BMC Pregnancy Childbirth. 2010 Dec 16;10:83. doi: 10.1186/1471-2393-10-83. BMC Pregnancy Childbirth. 2010. PMID: 21162725 Free PMC article. Clinical Trial.
Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial.
Jozwiak M, Oude Rengerink K, Benthem M, van Beek E, Dijksterhuis MG, de Graaf IM, van Huizen ME, Oudijk MA, Papatsonis DN, Perquin DA, Porath M, van der Post JA, Rijnders RJ, Scheepers HC, Spaanderman ME, van Pampus MG, de Leeuw JW, Mol BW, Bloemenkamp KW; PROBAAT Study Group. Jozwiak M, et al. Lancet. 2011 Dec 17;378(9809):2095-103. doi: 10.1016/S0140-6736(11)61484-0. Epub 2011 Oct 24. Lancet. 2011. PMID: 22030144 Clinical Trial.
Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.
Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KW, Scheepers HC, Bremer HA, Rijnders RJ, van Loon AJ, Perquin DA, Sporken JM, Papatsonis DN, van Huizen ME, Vredevoogd CB, Brons JT, Kaplan M, van Kaam AH, Groen H, Porath MM, van den Berg PP, Mol BW, Franssen MT, Langenveld J; HYPITAT-II study group. Broekhuijsen K, et al. Lancet. 2015 Jun 20;385(9986):2492-501. doi: 10.1016/S0140-6736(14)61998-X. Epub 2015 Mar 25. Lancet. 2015. PMID: 25817374 Clinical Trial.
Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT-II): a multicentre randomised controlled non-inferiority trial.
Ten Eikelder ML, Oude Rengerink K, Jozwiak M, de Leeuw JW, de Graaf IM, van Pampus MG, Holswilder M, Oudijk MA, van Baaren GJ, Pernet PJ, Bax C, van Unnik GA, Martens G, Porath M, van Vliet H, Rijnders RJ, Feitsma AH, Roumen FJ, van Loon AJ, Versendaal H, Weinans MJ, Woiski M, van Beek E, Hermsen B, Mol BW, Bloemenkamp KW. Ten Eikelder ML, et al. Lancet. 2016 Apr 16;387(10028):1619-28. doi: 10.1016/S0140-6736(16)00084-2. Epub 2016 Feb 3. Lancet. 2016. PMID: 26850983 Clinical Trial.
Women's Experiences with and Preference for Induction of Labor with Oral Misoprostol or Foley Catheter at Term.
Ten Eikelder ML, van de Meent MM, Mast K, Rengerink KO, Jozwiak M, de Graaf IM, Scholtenhuis MA, Roumen FJ, Porath MM, van Loon AJ, van den Akker ES, Rijnders RJ, Feitsma AH, Adriaanse AH, Muller MA, de Leeuw JW, Visser H, Woiski MD, Weerd SR, van Unnik GA, Pernet PJ, Versendaal H, Mol BW, Bloemenkamp KW. Ten Eikelder ML, et al. Am J Perinatol. 2017 Jan;34(2):138-146. doi: 10.1055/s-0036-1584523. Epub 2016 Jun 24. Am J Perinatol. 2017. PMID: 27341122
Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy.
Zwertbroek EF, Broekhuijsen K, Langenveld J, van Baaren GJ, van den Berg PP, Bremer HA, Ganzevoort W, van Loon AJ, Mol BW, van Pampus MG, Perquin DA, Rijnders RJ, Scheepers HC, Sikkema MJ, Woiski MD, Groen H, Franssen MT; HYPITAT-II Study Group. Zwertbroek EF, et al. Acta Obstet Gynecol Scand. 2017 Jan;96(1):96-105. doi: 10.1111/aogs.13051. Acta Obstet Gynecol Scand. 2017. PMID: 27792243 Free article.
Early enteral tube feeding in optimizing treatment of hyperemesis gravidarum: the Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding (MOTHER) randomized controlled trial.
Grooten IJ, Koot MH, van der Post JA, Bais JM, Ris-Stalpers C, Naaktgeboren C, Bremer HA, van der Ham DP, Heidema WM, Huisjes A, Kleiverda G, Kuppens S, van Laar JO, Langenveld J, van der Made F, van Pampus MG, Papatsonis D, Pelinck MJ, Pernet PJ, van Rheenen L, Rijnders RJ, Scheepers HC, Vogelvang TE, Mol BW, Roseboom TJ, Painter RC. Grooten IJ, et al. Am J Clin Nutr. 2017 Sep;106(3):812-820. doi: 10.3945/ajcn.117.158931. Epub 2017 Aug 9. Am J Clin Nutr. 2017. PMID: 28793989 Free article. Clinical Trial.
Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial.
Zwertbroek EF, Franssen MTM, Broekhuijsen K, Langenveld J, Bremer H, Ganzevoort W, van Loon AJ, van Pampus MG, Rijnders RJP, Sikkema MJ, Scherjon SA, Woiski MD, Mol BWJ, van Baar AL, Groen H; HYPITAT-II Study Group. Zwertbroek EF, et al. Am J Obstet Gynecol. 2019 Aug;221(2):154.e1-154.e11. doi: 10.1016/j.ajog.2019.03.024. Epub 2019 Mar 30. Am J Obstet Gynecol. 2019. PMID: 30940558 Clinical Trial.
Determinants of disease course and severity in hyperemesis gravidarum.
Koot MH, Grooten IJ, van der Post JAM, Bais JMJ, Ris-Stalpers C, Leeflang MMG, Bremer HA, van der Ham DP, Heidema WM, Huisjes A, Kleiverda G, Kuppens SM, van Laar JOEH, Langenveld J, van der Made F, van Pampus MG, Papatsonis D, Pelinck MJ, Pernet PJ, van Rheenen-Flach L, Rijnders RJ, Scheepers HCJ, Vogelvang TE, Mol BW, Roseboom TJ, Painter RC. Koot MH, et al. Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:162-167. doi: 10.1016/j.ejogrb.2019.12.021. Epub 2019 Dec 24. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 31923736
73 results